Form 4: Health Catalyst Director Receives RSU Award

Health Catalyst, Inc. reports that Director Steven H. Nelson was granted restricted stock units (RSUs) on May 1, 2026, with vesting scheduled over three years.

Summary

• Steven H. Nelson, a Director at Health Catalyst, Inc., received an award of 154,808 restricted stock units (RSUs) on May 1, 2026.
• These RSUs were granted under the Issuer's 2019 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• Vesting of the RSUs is structured such that 33.33% will vest on May 1, 2027, with the remaining 66.67% vesting in two equal annual installments thereafter.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director rather than a significant financial or strategic development for the company.

Positives

• Director Nelson received a significant RSU award, indicating continued investment in and alignment with the company's long-term success.
• The RSU award structure provides a multi-year vesting schedule, encouraging retention and sustained performance.
• The grant is made under an existing incentive plan, suggesting a consistent approach to executive and director compensation.

Risks

• The value of the RSU award is subject to the future performance of Health Catalyst, Inc.'s stock price.
• If the company's stock underperforms, the ultimate value realized by Director Nelson from this award could be diminished.

Future Outlook

The future outlook for the RSU award is tied to the vesting schedule, with portions vesting on May 1, 2027, and then annually thereafter. The ultimate value will depend on the company's stock performance.

Industry Context

StockSavvy.ai notes that the granting of RSUs to directors is a common practice in the technology and healthcare sectors, including companies like Health Catalyst, Inc., to align leadership interests with shareholder value over the long term.

Stakeholder Impact

• Shareholders: The RSU award represents potential dilution but also aligns director incentives with long-term shareholder value.
• Directors: Director Steven H. Nelson benefits from the RSU award, contingent on future company performance and vesting.
• Employees: The RSU award is part of the overall compensation structure, which can influence employee morale and retention.

Next Steps

• Vesting of 33.33% of RSUs on May 1, 2027.
• Subsequent vesting of remaining RSUs in two equal annual installments.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, SEC Filing, Restricted Stock Units, RSU Award, Director Compensation, Stock Options, Incentive Plan, Beneficial Ownership